Relmada Therapeutics Files 8-K
Ticker: RLMD · Form: 8-K · Filed: May 27, 2025 · CIK: 1553643
| Field | Detail |
|---|---|
| Company | Relmada Therapeutics, Inc. (RLMD) |
| Form Type | 8-K |
| Filed Date | May 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Relmada Therapeutics filed an 8-K on 5/23/25 covering shareholder votes and financials.
AI Summary
Relmada Therapeutics, Inc. filed an 8-K on May 23, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The company, formerly known as Camp Nine, Inc., is incorporated in Nevada and headquartered in Coral Gables, Florida.
Why It Matters
This filing indicates important corporate actions and financial reporting by Relmada Therapeutics, which could impact investors' understanding of the company's status and governance.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate financial distress or significant operational changes.
Key Numbers
- 001-39082 — SEC File Number (Identifies the company's filing with the SEC)
- 45-5401931 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- RELMADA THERAPEUTICS, INC. (company) — Registrant
- CAMP NINE, INC. (company) — Former company name
- May 23, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Coral Gables, FL (location) — Principal executive offices location
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in this excerpt.
What financial statements are being reported?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in this excerpt.
When was the company formerly known as Camp Nine, Inc.?
The date of the name change from Camp Nine, Inc. to Relmada Therapeutics, Inc. was July 6, 2012.
Where are Relmada Therapeutics' principal executive offices located?
The principal executive offices are located at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134.
What is Relmada Therapeutics' fiscal year end?
Relmada Therapeutics' fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding RELMADA THERAPEUTICS, INC. (RLMD).